Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 24035515)

1.

Radiochemical and radiobiological assessment of a pyridyl-S-cysteine functionalized bombesin derivative labeled with the (99m)Tc(CO)3(+) core.

Bouziotis P, Gourni E, Patsis G, Psimadas D, Zikos C, Fani M, Xanthopoulos S, Loudos G, Paravatou-Petsotas M, Livaniou E, Varvarigou AD, Pirmettis I, Papadopoulos M.

Bioorg Med Chem. 2013 Nov 1;21(21):6699-707. doi: 10.1016/j.bmc.2013.08.010. Epub 2013 Aug 12.

PMID:
24035515
3.

PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.

Däpp S, García Garayoa E, Maes V, Brans L, Tourwé DA, Müller C, Schibli R.

Nucl Med Biol. 2011 Oct;38(7):997-1009. doi: 10.1016/j.nucmedbio.2011.02.014. Epub 2011 Apr 21.

PMID:
21982571
4.

Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.

Kunstler JU, Veerendra B, Figueroa SD, Sieckman GL, Rold TL, Hoffman TJ, Smith CJ, Pietzsch HJ.

Bioconjug Chem. 2007 Sep-Oct;18(5):1651-61. Epub 2007 Jul 31.

PMID:
17663527
5.

Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.

Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Ramírez Fde M, Luna-Gutiérrez MA, Pedraza-López M, García-Becerra R, Ordaz-Rosado D.

Int J Pharm. 2009 Jun 22;375(1-2):75-83. doi: 10.1016/j.ijpharm.2009.04.018. Epub 2009 Apr 22.

PMID:
19393305
6.

The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals.

Prasanphanich AF, Lane SR, Figueroa SD, Ma L, Rold TL, Sieckman GL, Hoffman TJ, McCrate JM, Smith CJ.

In Vivo. 2007 Jan-Feb;21(1):1-16.

7.

Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.

Richter S, Wuest M, Krieger SS, Rogers BE, Friebe M, Bergmann R, Wuest F.

Nucl Med Biol. 2013 Nov;40(8):1025-34. doi: 10.1016/j.nucmedbio.2013.07.005. Epub 2013 Aug 19.

PMID:
23969085
8.

64Cu-NO2A-RGD-Glu-6-Ahx-BBN(7-14)NH2: a heterodimeric targeting vector for positron emission tomography imaging of prostate cancer.

Jackson AB, Nanda PK, Rold TL, Sieckman GL, Szczodroski AF, Hoffman TJ, Chen X, Smith CJ.

Nucl Med Biol. 2012 Apr;39(3):377-87. doi: 10.1016/j.nucmedbio.2011.10.004. Epub 2012 Jan 5.

9.

Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.

Okarvi SM, Al Jammaz I.

Nucl Med Biol. 2010 Apr;37(3):277-88. doi: 10.1016/j.nucmedbio.2009.12.006. Epub 2010 Feb 10.

PMID:
20346867
10.

Spacer site modifications for the improvement of the in vitro and in vivo binding properties of (99m)Tc-N(3)S-X-bombesin[2-14] derivatives.

Fragogeorgi EA, Zikos C, Gourni E, Bouziotis P, Paravatou-Petsotas M, Loudos G, Mitsokapas N, Xanthopoulos S, Mavri-Vavayanni M, Livaniou E, Varvarigou AD, Archimandritis SC.

Bioconjug Chem. 2009 May 20;20(5):856-67. doi: 10.1021/bc800475k.

PMID:
19344122
11.

Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.

Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, Smith CJ.

Nucl Med Biol. 2008 May;35(4):401-11. doi: 10.1016/j.nucmedbio.2008.02.005.

PMID:
18482677
12.

Impact of functionalized coligands on the pharmacokinetics of 99mTcIII '4+1' mixed-ligand complexes conjugated to bombesin.

Kunstler JU, Bergmann R, Gniazdowska E, Koźmiński P, Walther M, Pietzsch HJ.

J Inorg Biochem. 2011 Nov;105(11):1383-90. doi: 10.1016/j.jinorgbio.2011.07.002. Epub 2011 Aug 8.

PMID:
21946438
13.

Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.

Smith CJ, Sieckman GL, Owen NK, Hayes DL, Mazuru DG, Volkert WA, Hoffman TJ.

Anticancer Res. 2003 Jan-Feb;23(1A):63-70.

PMID:
12680195
14.

A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.

Pan D, Xu YP, Yang RH, Wang L, Chen F, Luo S, Yang M, Yan Y.

Amino Acids. 2014 Jun;46(6):1481-9. doi: 10.1007/s00726-014-1718-y. Epub 2014 Mar 17.

PMID:
24633452
15.
16.

99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer.

Shi J, Jia B, Liu Z, Yang Z, Yu Z, Chen K, Chen X, Liu S, Wang F.

Bioconjug Chem. 2008 Jun;19(6):1170-8. doi: 10.1021/bc700471z. Epub 2008 May 21.

PMID:
18491928
17.
18.

Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.

Bandari RP, Jiang Z, Reynolds TS, Bernskoetter NE, Szczodroski AF, Bassuner KJ, Kirkpatrick DL, Rold TL, Sieckman GL, Hoffman TJ, Connors JP, Smith CJ.

Nucl Med Biol. 2014 Apr;41(4):355-63. doi: 10.1016/j.nucmedbio.2014.01.001. Epub 2014 Jan 10.

19.

99mTc(v)O-Gly-Gly-Cys-Orn-Orn-Orn-Bombesin[2-14].

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2009 Aug 19 [updated 2009 Sep 23].

20.

Novel, cysteine-modified chelation strategy for the incorporation of [M(I)(CO)(3)](+) (M = Re, (99m)Tc) in an α-MSH peptide.

Jiang H, Kasten BB, Liu H, Qi S, Liu Y, Tian M, Barnes CL, Zhang H, Cheng Z, Benny PD.

Bioconjug Chem. 2012 Nov 21;23(11):2300-12. doi: 10.1021/bc300509k. Epub 2012 Nov 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk